2-benzylmalonate has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Peng, T; Suksamrarn, A; Wang, F; Wonganan, O; Xi, R; Yu, J; Zhang, G; Zhang, Z | 1 |
1 other study(ies) available for 2-benzylmalonate and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
A 2-Benzylmalonate Derivative as STAT3 Inhibitor Suppresses Tumor Growth in Hepatocellular Carcinoma by Upregulating β-TrCP E3 Ubiquitin Ligase.
Topics: Animals; beta-Transducin Repeat-Containing Proteins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Male; Malonates; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Phosphorylation; Recombinant Proteins; Response Elements; STAT3 Transcription Factor; Transducin; Ubiquitin-Protein Ligases; Up-Regulation | 2021 |